Ishiwata K, Ogi N, Shimada J, Wang W, Ishii K, Tanaka A, Suzuki F, Senda M
Positron Medical Center, Tokyo Metropolitan Institute of Gerontology, Itabashi, Japan.
Ann Nucl Med. 2000 Dec;14(6):461-6. doi: 10.1007/BF02988292.
We have evaluated the feasibility of using four positron emission tomography (PET) tracers for imaging the globus pallidus by ex vivo autoradiography in rats. The tracers investigated were [11C]KF18446, [11C]SCH 23390 and [11C]raclopride for mapping adenosine A2A, dopamine D1 and dopamine D2 receptors, respectively, and [18F]FDG. The highest uptake by the globus pallidus was found for [11C]SCH 23390, followed by [18F]FDG, [11C]KF18446 and [11C]raclopride. The receptor-specific uptake by the globus pallidus was observed in [11C]KF18446 and [11C]SCH 23390, but not in [11C]raclopride. Uptake ratios of globus pallidus to the striatum for [18F]FDG and [11C]KF18446 were approximately 0.6, which was twice as large as that for [11C]SCH 23390. In a rat model of degeneration of striatopallidal gamma-aminobutyric acid-ergic-enkephalin neurons induced by intrastriatal injection of quinolinic acid, the uptake of [11C]KF18446 by the striatum and globus pallidus was remarkably reduced. To prove the visualization of the globus pallidus by PET with [18F]FDG and [11C]KF18446, PET-MRI registration technique and advances in PET technologies providing high-resolution PET scanner will be required. The metabolic activity of the globus pallidus could then be measured by PET with [18F]FDG, and [11C]KF18446 may be a candidate tracer for imaging the pallidal terminals projecting from the striatum.
我们通过大鼠离体放射自显影评估了使用四种正电子发射断层扫描(PET)示踪剂对苍白球进行成像的可行性。所研究的示踪剂分别为用于绘制腺苷A2A、多巴胺D1和多巴胺D2受体图谱的[11C]KF18446、[11C]SCH 23390和[11C]雷氯必利,以及[18F]氟代脱氧葡萄糖([18F]FDG)。发现苍白球对[11C]SCH 23390的摄取最高,其次是[18F]FDG、[11C]KF18446和[11C]雷氯必利。在[11C]KF18446和[11C]SCH 23390中观察到苍白球的受体特异性摄取,但在[11C]雷氯必利中未观察到。[18F]FDG和[11C]KF18446的苍白球与纹状体摄取比约为0.6,是[11C]SCH 23390的两倍。在通过纹状体内注射喹啉酸诱导的纹状体苍白球γ-氨基丁酸能脑啡肽能神经元变性的大鼠模型中,纹状体和苍白球对[11C]KF18446的摄取显著降低。为了通过[18F]FDG和[11C]KF18446的PET证明苍白球的可视化,将需要PET-MRI配准技术以及提供高分辨率PET扫描仪的PET技术进步。然后可以通过[18F]FDG的PET测量苍白球的代谢活性,并且[11C]KF18446可能是用于对从纹状体投射的苍白球终末进行成像的候选示踪剂。